Sweta Chakraborty
Print version
Contact details
King's Centre for Risk Management
Department of Geography
King's College London
Strand
London WC2R 2LS
Tel: +44 (0)20 7848 1173
Email: sweta.chakraborty@kcl.ac.uk
Department of Geography
King's College London
Strand
London WC2R 2LS
Tel: +44 (0)20 7848 1173
Email: sweta.chakraborty@kcl.ac.uk
Biography
Sweta Chakraborty is currently a 3rd year PhD student at the King’s Centre for Risk Management. She is originally from NYC and joined KCRM after graduating in 2006 from Carnegie Mellon University with a BSc in Decision Science and a BA in International Relations. She spent her third undergraduate year at the London School of Economics, exploring her interest in risk analysis from a European perspective.
While her PhD specifically explores risk perception and communication related to chronic prescription drug taking, she is broadly interested in pharmaceutical and public health issues on a global scale. This stems from her work experience at Pfizer Inc. and extensive research looking at public reactions to drug safety scares.
While her PhD specifically explores risk perception and communication related to chronic prescription drug taking, she is broadly interested in pharmaceutical and public health issues on a global scale. This stems from her work experience at Pfizer Inc. and extensive research looking at public reactions to drug safety scares.
Research
PhD title: Communicating Risk in a Distrustful Environment: A Critical Analysis on the Role of Trust in Patient Adherence to Treatment Regimens
Sweta is exploring the extent to which trust plays a role in patient adherence to their drug treatment regimens in relation to all other potential factors. She is applying the mental models approach in order to uncover implicit attitudes that may be linked to a patient’s decision behind complying with his or her physician’s treatment instructions.
Key areas of research: Risk perception/communication/regulation, social trust, mental models methodology, pharmaceutical and public health sector
Supervisors: Professor Ragnar Lofstedt and Dr Henry Rothstein
Sweta is exploring the extent to which trust plays a role in patient adherence to their drug treatment regimens in relation to all other potential factors. She is applying the mental models approach in order to uncover implicit attitudes that may be linked to a patient’s decision behind complying with his or her physician’s treatment instructions.
Key areas of research: Risk perception/communication/regulation, social trust, mental models methodology, pharmaceutical and public health sector
Supervisors: Professor Ragnar Lofstedt and Dr Henry Rothstein
Presentations
7-10 Dec 2008: Society for Risk Analysis annual conference: Risk Analysis: The Science and the Art, Boston, MA
-Presenting paper entitled “A Critical Analysis on the Role of Trust in Patient Adherence to Treatment Regimens” Abstract available at: http://birenheide.com/sra/2008AM/program/singlesession.php3?sessid=W3-B
9-12 Dec 2007: Society for Risk Analysis annual conference: Risk 007: Agents of Analysis, San Antonio, TX
- Presented paper entitled: "Prescription Medications, Patients, and Consensual Decision-Making: A Challenge for Pharmaceutical Risk Management" (Abstract).
31 Oct 2007: Royal Society of Arts Risk Commission conference: Risk and Childhood, London, UK
-Student Delegate
20 Sept. 2007: LSE Centre for Analysis of Risk and Regulation (CARR) Annual PhD conference, London, UK
-Invited after competitive application process to present thesis work to date for peer and critical review by well-renowned scholars in the field of risk.
10-12 August 2006: Risk Com 2006 conference at Gothenburg University, Gothenburg, Sweden
-Presented paper entitled: "Increased Scrutiny of the Pharmaceutical Industry and its Implications in Public Perceptions of Risk".
-Presenting paper entitled “A Critical Analysis on the Role of Trust in Patient Adherence to Treatment Regimens” Abstract available at: http://birenheide.com/sra/2008AM/program/singlesession.php3?sessid=W3-B
9-12 Dec 2007: Society for Risk Analysis annual conference: Risk 007: Agents of Analysis, San Antonio, TX
- Presented paper entitled: "Prescription Medications, Patients, and Consensual Decision-Making: A Challenge for Pharmaceutical Risk Management" (Abstract).
31 Oct 2007: Royal Society of Arts Risk Commission conference: Risk and Childhood, London, UK
-Student Delegate
20 Sept. 2007: LSE Centre for Analysis of Risk and Regulation (CARR) Annual PhD conference, London, UK
-Invited after competitive application process to present thesis work to date for peer and critical review by well-renowned scholars in the field of risk.
10-12 August 2006: Risk Com 2006 conference at Gothenburg University, Gothenburg, Sweden
-Presented paper entitled: "Increased Scrutiny of the Pharmaceutical Industry and its Implications in Public Perceptions of Risk".
